151 related articles for article (PubMed ID: 10497157)
1. Identification of the potassium channel opener site on sulfonylurea receptors.
Uhde I; Toman A; Gross I; Schwanstecher C; Schwanstecher M
J Biol Chem; 1999 Oct; 274(40):28079-82. PubMed ID: 10497157
[TBL] [Abstract][Full Text] [Related]
2. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
[TBL] [Abstract][Full Text] [Related]
3. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.
Dörschner H; Brekardin E; Uhde I; Schwanstecher C; Schwanstecher M
Mol Pharmacol; 1999 Jun; 55(6):1060-6. PubMed ID: 10347249
[TBL] [Abstract][Full Text] [Related]
4. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.
Ashfield R; Gribble FM; Ashcroft SJ; Ashcroft FM
Diabetes; 1999 Jun; 48(6):1341-7. PubMed ID: 10342826
[TBL] [Abstract][Full Text] [Related]
5. Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A, and SUR2B.
Matsuo M; Tanabe K; Kioka N; Amachi T; Ueda K
J Biol Chem; 2000 Sep; 275(37):28757-63. PubMed ID: 10893240
[TBL] [Abstract][Full Text] [Related]
6. ATP-Sensitive K+ channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADP.
Hambrock A; Löffler-Walz C; Kloor D; Delabar U; Horio Y; Kurachi Y; Quast U
Mol Pharmacol; 1999 May; 55(5):832-40. PubMed ID: 10220561
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6.x subtypes.
Hambrock A; Löffler-Walz C; Russ U; Lange U; Quast U
Mol Pharmacol; 2001 Jul; 60(1):190-9. PubMed ID: 11408614
[TBL] [Abstract][Full Text] [Related]
8. Pharmaco-topology of sulfonylurea receptors. Separate domains of the regulatory subunits of K(ATP) channel isoforms are required for selective interaction with K(+) channel openers.
Babenko AP; Gonzalez G; Bryan J
J Biol Chem; 2000 Jan; 275(2):717-20. PubMed ID: 10625598
[TBL] [Abstract][Full Text] [Related]
9. Structural requirements of sulphonylureas and analogues for interaction with sulphonylurea receptor subtypes.
Meyer M; Chudziak F; Schwanstecher C; Schwanstecher M; Panten U
Br J Pharmacol; 1999 Sep; 128(1):27-34. PubMed ID: 10498831
[TBL] [Abstract][Full Text] [Related]
10. Interaction of K(ATP) channel modulators with sulfonylurea receptor SUR2B: implication for tetramer formation and allosteric coupling of subunits.
Löffler-Walz C; Hambrock A; Quast U
Mol Pharmacol; 2002 Feb; 61(2):407-14. PubMed ID: 11809866
[TBL] [Abstract][Full Text] [Related]
11. Coassembly of different sulfonylurea receptor subtypes extends the phenotypic diversity of ATP-sensitive potassium (KATP) channels.
Wheeler A; Wang C; Yang K; Fang K; Davis K; Styer AM; Mirshahi U; Moreau C; Revilloud J; Vivaudou M; Liu S; Mirshahi T; Chan KW
Mol Pharmacol; 2008 Nov; 74(5):1333-44. PubMed ID: 18723823
[TBL] [Abstract][Full Text] [Related]
12. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
[TBL] [Abstract][Full Text] [Related]
13. NMR and fluorescence studies of drug binding to the first nucleotide binding domain of SUR2A.
López-Alonso JP; de Araujo ED; Kanelis V
Biochemistry; 2012 Nov; 51(45):9211-22. PubMed ID: 23078514
[TBL] [Abstract][Full Text] [Related]
14. Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide.
Russ U; Hambrock A; Artunc F; Löffler-Walz C; Horio Y; Kurachi Y; Quast U
Mol Pharmacol; 1999 Nov; 56(5):955-61. PubMed ID: 10531400
[TBL] [Abstract][Full Text] [Related]
15. Effect of two amino acids in TM17 of Sulfonylurea receptor SUR1 on the binding of ATP-sensitive K+ channel modulators.
Hambrock A; Kayar T; Stumpp D; Osswald H
Diabetes; 2004 Dec; 53 Suppl 3():S128-34. PubMed ID: 15561900
[TBL] [Abstract][Full Text] [Related]
16. Role of the amino-terminal transmembrane domain of sulfonylurea receptor SUR2B for coupling to K(IR)6.2, ligand binding, and oligomerization.
Winkler M; Kühner P; Russ U; Ortiz D; Bryan J; Quast U
Naunyn Schmiedebergs Arch Pharmacol; 2012 Mar; 385(3):287-98. PubMed ID: 22089636
[TBL] [Abstract][Full Text] [Related]
17. The molecular basis of the specificity of action of K(ATP) channel openers.
Moreau C; Jacquet H; Prost AL; D'hahan N; Vivaudou M
EMBO J; 2000 Dec; 19(24):6644-51. PubMed ID: 11118199
[TBL] [Abstract][Full Text] [Related]
18. C-terminal tails of sulfonylurea receptors control ADP-induced activation and diazoxide modulation of ATP-sensitive K(+) channels.
Matsuoka T; Matsushita K; Katayama Y; Fujita A; Inageda K; Tanemoto M; Inanobe A; Yamashita S; Matsuzawa Y; Kurachi Y
Circ Res; 2000 Nov; 87(10):873-80. PubMed ID: 11073882
[TBL] [Abstract][Full Text] [Related]
19. [Activation of ATP-sensitive K+ channels by ADP and K+ channel openers: homology model of sulfonylurea receptor carboxyl-termini].
Fujita A; Matsuoka T; Matsushita K; Kurachi Y
Nihon Yakurigaku Zasshi; 2001 Sep; 118(3):177-86. PubMed ID: 11577458
[TBL] [Abstract][Full Text] [Related]
20. Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1(M1289T).
Hambrock A; de Oliveira Franz CB; Hiller S; Osswald H
J Pharmacol Exp Ther; 2006 Mar; 316(3):1031-7. PubMed ID: 16306272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
